Combining Cell Technologies With Biomimetic Tissue Engineering Applications: A New Paradigm for Translational Cardiovascular Therapies

Cardiovascular disease is a major cause of morbidity and mortality worldwide and, to date, the clinically available prostheses still present several limitations. The design of next-generation regenerative replacements either based on cellular or extracellular matrix technologies can address these sh...

Full description

Saved in:
Bibliographic Details
Published in:Stem cells translational medicine 2023-03, Vol.12 (2), p.72-82
Main Authors: Motta, Sarah E, Martin, Marcy, Gähwiler, Eric K N, Visser, Valery L, Zaytseva, Polina, Ehterami, Arian, Hoerstrup, Simon P, Emmert, Maximilian Y
Format: Article
Language:English
Subjects:
Biomimetics
Cardiovascular Diseases - therapy
Concise Reviews
Extracellular Matrix
Humans
Induced Pluripotent Stem Cells
Tissue Engineering
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular disease is a major cause of morbidity and mortality worldwide and, to date, the clinically available prostheses still present several limitations. The design of next-generation regenerative replacements either based on cellular or extracellular matrix technologies can address these shortcomings. Therefore, tissue engineered constructs could potentially become a promising alterative to the current therapeutic options for patients with cardiovascular diseases. In this review, we selectively present an overview of the current tissue engineering tools such as induced pluripotent stem cells, biomimetic materials, computational modeling, and additive manufacturing technologies, with a focus on their application to translational cardiovascular therapies. We discuss how these advanced technologies can help the development of biomimetic tissue engineered constructs and we finally summarize the latest clinical evidence for their use, and their potential therapeutic outcome.
ISSN:2157-6564
2157-6580
2157-6580
DOI:10.1093/stcltm/szad002